For the treatment of moderate and severe chronic circulatory disorders of peripheral arteries ( e . g ., arteriosclerosis obliterans, thromboangiitis obliterans, diabetic microangiopathy and Raynaud's phenomenon ).
2.
It is used in peripheral vascular diseases, like arteriosclerosis obliterans, Raynaud's disease, thromboangiitis obliterans ( Buerger's disease ), arterial embolism, chilblains or migraine associated with vascular spasm.
3.
;CLBS12 : ( autologous CD34 + cells ) for critical limb ischemia ( CLI ) due to arteriosclerosis obliterans ( ASO ) . this phase 2 trial has not started . ( CD34 + cells include many types of hematopoietic stem cell .)
परिभाषा
a stage of arteriosclerosis involving closure of blood vessels
मोबाइल